Teva Canada Recalls Acetaminophen Over Resin Risk

Teva Canada has recalled a single lot of its Novo-Gesic Forte 500 mg acetaminophen tablets after finding the tablets may contain fragments of phenolic resin or epoxy — materials Health Canada says could injure the digestive tract if swallowed. The recall, posted 10 September, covers one manufacturing lot shipped to pharmacies nationwide in bulk 1,000-count bottles, a distribution pattern that makes it harder to trace than a typical single-package retail recall.

A contamination issue, not a formulation defect

The recall notice describes a foreign-material problem rather than a potency, stability, or active-ingredient issue: something — described as phenolic resin or epoxy — ended up mixed into or on the tablets themselves. That points toward the manufacturing or packaging line rather than the drug's formulation, the kind of failure a quality system is built to catch before a lot ships. Neither Health Canada's notice nor Teva Canada's own alert has published a root-cause explanation for how the contaminant entered this specific lot. Health Canada says it is monitoring the company's corrective and preventive actions and will update the public if new safety information emerges — language that leaves open whether other lots from the same line face scrutiny.

Why a bulk-bottle recall is harder to trace

Novo-Gesic Forte reached pharmacies in 1,000-count bottles, which pharmacists then portioned into smaller quantities for individual patients. That distribution model is common for high-volume generic OTC analgesics, but it means a patient holding a small vial of tablets from a pharmacy has no easy way to see the original lot number on their own container — the traceability sits with the pharmacy's dispensing records, not the product in a patient's medicine cabinet. Health Canada's guidance reflects that: rather than telling consumers to check a lot number themselves, it directs anyone who received the product to return it to their pharmacy, which can confirm against its own records whether the recalled lot was involved.

The recall is limited to the Canadian market. Novo-Gesic Forte is a Teva Canada domestic brand, and no parallel U.S. FDA action or distribution has been identified in connection with this lot as of this writing.